A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.
Clinical trial NCT07053137 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07053137
- Sponsor
- Yipeng Liu
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-11-30
- Primary completion
- 2026-03-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.